HIV Gene Therapy
Cells Transfected With Non-Neutralizing Antibody Gene Resist Infection
Published in Cancer Weekly, March 23rd, 1998
T cells and macrophages are easily infected by HIV. Once inside the cells, the virus is no longer accessible to neutralizing antibodies. This makes HIV an ideal candidate for intracellular gene therapy.
Paul Zhou and colleagues from the U.S. National Institutes of Health, Maryland, constructed plasmids containing single chain Fv (scFv) non-neutralizing human anti-HIV-1 gp41 Ab cDNA and tested their anti-HIV activity in vitro ("Cells Transfected with a Non-Neutralizing Antibody Gene are Resistant to HIV Infection: Targeting the Endoplasmic Reticulum and...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (1998-03-23)
More Articles from Cancer Weekly
- DNA Vaccines
Genetically Modified Dendritic Cells Elicit Immune Responses - Cancer Immunotherapy
Single Chain IL-12 Fusion Protein Induces Protective Immunity - Cancer Immunotherapy
Targeted IL-2 Gene Therapy Eradicates Neuroblastoma Metastases - Vector Development
Selective Gene Transfer Via Inverse Targeting of Retroviral Vectors - Prostate Cancer (Research)
PSCA as a Target for Prostate Cancer Diagnosis and Therapy - Breast Cancer
Study Reports U.S. Women Surviving Cancer Longer - More from this issue of Cancer Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
